Key result
Fatigue was initially associated with nonfatal ischemic heart disease, but this became nonsignificant after multivariable adjustment (HR 1.57; 95% CI 0.82-3.01), though it remained a strong predictor in nonsmokers.
Why the study?
Does self-reported fatigue predict nonfatal ischemic heart disease and all-cause mortality in middle-aged men?
Cohort (n=5,216)
Does self-reported fatigue predict nonfatal ischemic heart disease and all-cause mortality in middle-aged men?
Hazard Ratio: 1.57 (95% CI 0.82–3.01)
p-value: p=nonsignificant
Fatigue is a potential risk indicator for IHD and mortality in middle-aged men, particularly among nonsmokers, though multivariable adjustment attenuates the overall association.
Fatigue should not yet inform IHD risk stratification; hypothesis-generating in nonsmokers and requires prospective validation.
OBJECTIVE: To investigate whether fatigue predicts nonfatal ischemic heart disease (IHD) and all-cause mortality in middle-aged men. METHODS: The study population consisted of 5216 middle-aged men born in the Copenhagen metropolitan area in 1953. At baseline, men free of angina pectoris and previous IHD were asked if they felt fatigued. Information on IHD diagnosis and all-cause mortality was register based. The Cox proportional hazard model was used to test the association at 4-year follow-up. RESULTS: Fatigue was associated with hospitalization for nonfatal IHD (hazard ratio [HR] = 1.98, 95% confidence interval [CI] = 1.09-3.61) and all-cause mortality (HR = 3.99, 95% CI = 2.27-7.02). These associations became nonsignificant in multivariable-adjusted models (HR = 1.57, 95% CI = 0.82-3.01 and HR = 1.90, 95% CI = 0.95-3.80). Imputation of missing data did not modify conclusions. Fatigue was a strong independent predictor of first hospitalization for nonfatal IHD among nonsmoking men (HR = 6.00, 95% CI = 2.00-18.04), and the fatigue-by-smoking status interaction was significant (p = .04). Findings should be interpreted with caution because of the small number of participants with IHD (n = 21, 1.5%). Compared to nonfatigued nonsmokers, both fatigued nonsmokers and fatigued smokers had higher hazard of dying (HR = 4.99, 95% CI = 1.31-19.09 and HR = 3.74, 95% CI = 1.32-10.57, respectively), although the fatigue-by-smoking status interaction was not significant (p = .12). CONCLUSIONS: Fatigue is a potential risk indicator for IHD and mortality. Further research is needed to establish the role of smoking and other life-style characteristics.
No takes yet. Share an insight, caveat, or question.
Ekmann et al. (2012) conducted a cohort in Nonfatal ischemic heart disease and all-cause mortality (n=5,216). Fatigue vs. No fatigue was evaluated on Hospitalization for nonfatal ischemic heart disease (multivariable-adjusted) (HR 1.57, 95% CI 0.82-3.01, p=nonsignificant). Fatigue was initially associated with nonfatal ischemic heart disease, but this became nonsignificant after multivariable adjustment (HR 1.57; 95% CI 0.82-3.01), though it remained a strong predictor in nonsmokers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: